‌

US Patent 8399456 2,5-disubstituted arylsulfonamide CCR3 antagonists

Patent 8399456 was granted and assigned to Axikin Pharmaceuticals on March, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Axikin Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8399456

Patent Inventor Names

Tai Wei Ly0

Erik Dean Raaum0

Marie Chantal Siu-Ying Tran0

Date of Patent

March 19, 2013

Patent Application Number

12764900

Date Filed

April 21, 2010

Patent Primary Examiner

‌

Kristin Bianchi

Patent abstract

Provided herein are 2,5-disubstituted arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.